Global Journal of Pharmacy & Pharmaceutical Sciences 4:110114 Daquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, Kasse CM, Yan J, Prossnitz AN, Chang E, Baker SW, Hovgaard L, Steensgaard DB, Andersen HB, Simonsen L, Appel EA (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management
doi: 10.1111/ddg.14314
Some studies suggest that higher doses, up to 2,000 mg per day , may be beneficial for specific conditions, such as chronic illness or high oxidative stress
Expression of mt-roGFP in park 13 tyrosine hydroxylase positive neurons showed significantly reduced mitochondrial ROS accumulation under Sp treatment as compared to untreated ones, highlighting potential mitochondrial recovery and prevention of oxidation induced cell death in dopamine producing neurons (Fig
Hemodynamic changes associated with GLP-1 therapy may also contribute to heart rate elevation
Their integration with redox homeostasis, phytohormone signaling, and environmental sensing pathways positions flavonoid metabolism at the interface between stress perception and adaptive responses (Mathesius, 2018)